EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

An NFATC4 phospho-switch links matrix stiffness to fibroblast fate

Rebecca Shelley Frabotta, Purushothama Rao Tata

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci209849 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Rebecca Shelley Frabotta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Extracellular Matrix, NFATC Transcription Factors, Fibroblasts, Myofibroblasts. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is driven by the activation of quiescent fibroblasts into contractile, matrix-secreting myofibroblasts, a transition governed jointly by biochemical signals and by the mechanical properties of the ECM. How the physical stiffness of tissue is converted into a durable transcriptional cell fate decision has remained poorly understood. In this issue of the JCI , Kadri et al. used global phosphoproteomic profiling of primary human lung fibroblasts across a defined stiffness gradient to identify phosphorylation of NFATC4 at residues S213/S217 as a mechanosensitive switch that is both necessary and sufficient for the fibroblast-to-myofibroblast transition. They validated these predictions in an independent transcriptomic dataset from patients with idiopathic pulmonary fibrosis, showing that NFATC4 expression increased with disease severity. Prior work has implicated NFATC4 activation in cardiac and hepatic fibrosis, suggesting that this single modification may serve as a convergence point for mechanical and cytokine signals across fibrotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular MatrixNFATC Transcription FactorsFibroblastsMyofibroblastsIdiopathic Pulmonary FibrosisHumansPhosphorylationAnimalsMechanotransduction, Cellular

Substanzen

NFATC Transcription Factors

Autor:innen und Institutionen

  • Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Duke Regeneration Center, Duke University, Durham, North Carolina, USA.
  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Center for Advanced Genomic Technologies, Duke University, Durham, North Carolina, USA.
  • Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Frabotta, R. S., & Tata, P. R. (2026). An NFATC4 phospho-switch links matrix stiffness to fibroblast fate. Journal of Clinical Investigation. https://doi.org/10.1172/jci209849

Vancouver

Frabotta RS, Tata PR. An NFATC4 phospho-switch links matrix stiffness to fibroblast fate. Journal of Clinical Investigation. 2026. doi:10.1172/jci209849

BibTeX
@article{Frabotta2026,
  author = {Frabotta, Rebecca Shelley and Tata, Purushothama Rao},
  title = {An NFATC4 phospho-switch links matrix stiffness to fibroblast fate},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci209849}
}
Kostenlos starten →